Neurogenin-1 (NGN1)

Neurogenin-1 is a basic helix-loop-helix (bHLH) transcription factor encoded by the NEUROG1 gene that serves as a key regulator of neuronal differentiation and lineage specification during embryonic development in vertebrates and some invertebrates[1][5][7]. Its function is to bind specific DNA enhancer elements (E box motifs, 5'-CANNTG-3') as a dimer (often with other bHLH proteins) to activate the transcription of downstream genes crucial for neuronal fate determination and morphogenesis[1][7]. Neurogenin-1 is essential for the generation of various neuronal subtypes by acting upstream of other transcriptional regulators, such as NeuroD, and is involved in processes such as cranial nerve and cochlea development[5][1][3]. The molecule is evolutionarily conserved and functions as one of the key "proneural" genes, marking progenitor cells for the neural lineage and initiating neurogenesis[1][3]. Disruption of Neurogenin-1 function is implicated in developmental disorders affecting the nervous system[5]. - Canonical name and abbreviation are standardized based on gene nomenclature databases and literature conventions[5][8]. - Molecular classification is clearly as a transcription factor—specifically, a basic helix-loop-helix type[1][5][7]. - Disease associations are primarily developmental; there is no evidence that Neurogenin-1 itself is a direct therapeutic target, as it is a developmental regulator and not a typical druggable protein (e.g., receptor, enzyme)[5][8]. - No interacting drugs, mechanisms of action for small molecules, or established biomarker or safety concern data are reported. If you need information relevant to a different biological context or wish to inquire about a closely related molecule, such as Neurogenin-2 or its targets, please clarify.

Other names

NEUROG1Math4CNEUROD3bHLHa6ngn1[8]